Effect of Age on the Renal Clearance of Adefovir

Withdrawn before enrolling · Phase 4

Conditions studied: Other Conditions That May Be A Focus of Clinical Attention

In brief

Healthy African American subjects with normal hepatic and renal function will be administered 10mg adefovir dipivoxil in a fasting state. Subjects will have blood and urine collections over the following 24 hours for the measurement of adefovir renal clearance. To investigate the role of age in renal adefovir elimination, 8 subjects will be enrolled from each of the following age groups: 18-25 years and 48-55 years.

Key facts

Study ID
NCT00187746
Run by
University of California, San Francisco
People needed
0
Starts
2005-08-01
Expected to finish
2008-04-01
Last updated by the study team
2012-11-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.